Jeremy Howick

Last updated

Jeremy Howick
Jeremy Howick.jpg
Born
Jeremy Howick

NationalityCanadian and British
CitizenshipCanadian and British
Education Dartmouth College
London School of Economics
University of Oxford
Occupation(s) Philosopher, Epidemiologist
Years active2009–present
Known forDoctor You
The Philosophy of Evidence-Based Medicine
Medical career
ProfessionPhilosopher, clinical epidemiologist, teacher
InstitutionsUniversity of Leicester and University of Oxford
Sub-specialtiesevidence-based medicine, placebo and nocebo effects, empathy in medicine
Website www.jeremyhowick.com

Jeremy Howick is a Canadian-born, British residing clinical epidemiologist and philosopher of science. He researches evidence-based medicine, clinical empathy and the philosophy of medicine, including the use of placebos in clinical practice and clinical trials. [1] [2] He is the author of over 100 peer-reviewed papers, as well as two books, The Philosophy of Evidence-Based Medicine in 2011, [3] and Doctor You in 2017. [4] In 2016, he received the Dawkins & Strutt grant from the British Medical Association to study pain treatment. [5] He publishes in Philosophy of Medicine and medical journals. [6] He is a member of the Sigma Xi research honours society. [7]

Contents

Early life and education

Howick, a native of Montreal, Canada, is a graduate of Westmount High School. He holds a Bachelor of Arts in Engineering from the Dartmouth College, and graduate degrees from The London School of Economics and the University of Oxford. His PhD in Philosophy of medicine at the London School of Economics was conducted under the supervision of Professors Nancy Cartwright and John Worrall, with a thesis entitled Philosophical essentials in evidence-based medicine: Evaluating the epistemological role of double blinding and placebo controls, published in 2008. [8] He is the Director of the Oxford Empathy Programme [9] at the Faculty of Philosophy, University of Oxford.

International Rowing

As a freshman at Dartmouth College, Howick learned to row. He subsequently competed in internationals for Canada at the 1994 World Championships, and won a silver medal at the 1994 Commonwealth Games. [10] He also competed in The Boat Race 1996 representing Oxford.[ citation needed ]

Professional background

Howick has worked at the University of Oxford, including at the Centre for Evidence-Based Medicine since 2007. Together with Muir Gray, he founded the Oxford Empathy Programme, [9] and the Oxford Philosophy and Medicine Network. [11] His main post now is at the University of Leicester where he is the director of the Stoneygate Centre for Excellence in Empathic Healthcare. [12]

Broadcasting

Howick designed a trial of placebo treatments for back pain for a BBC Horizon documentary. [13]

Research

Howick is known for his research which combines Philosophy of medicine with medical research (especially Evidence-based medicine, which he mostly defends. [14] Howick's book, "The Philosophy of Evidence-Based Medicine" came to define a sub-discipline within the Philosophy of Medicine [3] and has been used to develop a course on the History and Philosophy of Medicine at the Oxford Centre for Evidence-Based Medicine. The book is a critical defense of the Evidence-based medicine Hierarchy of evidence.

His research currently focuses on empathy, where his main contribution has been to evaluate empathy in healthcare the same way drugs are evaluated, namely with systematic reviews of randomised trials. [15] [16] He recently conducted a study showing that the definition of empathy is not as confusing as previously assumed. [17]

His work on placebo effects culminated in a book The Power of Placebos: How the Science of Placebos and Nocebos Can Improve Health Care. [18] His research in this area also includes a systematic review suggesting that the magnitude of placebo effects is similar to the magnitude of drug effects, most notably for treating pain (although the latter includes the placebo effect). [19] and another suggesting that 'honest' placebos (that patients know are placebos) can also be effective. [20]

His research has been translated for popular audiences in his book Doctor You. [21]

Related Research Articles

<span class="mw-page-title-main">Antidepressant</span> Class of medication used to treat depression and other conditions

Antidepressants are a class of medications used to treat major depressive disorder, anxiety disorders, chronic pain, and addiction.

Evidence-based medicine (EBM) is "the conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients. ... [It] means integrating individual clinical expertise with the best available external clinical evidence from systematic research." The aim of EBM is to integrate the experience of the clinician, the values of the patient, and the best available scientific information to guide decision-making about clinical management. The term was originally used to describe an approach to teaching the practice of medicine and improving decisions by individual physicians about individual patients.

<span class="mw-page-title-main">Placebo</span> Substance or treatment of no therapeutic value

A placebo is a substance or treatment which is designed to have no therapeutic value. Common placebos include inert tablets, inert injections, sham surgery, and other procedures.

In a blind or blinded experiment, information which may influence the participants of the experiment is withheld until after the experiment is complete. Good blinding can reduce or eliminate experimental biases that arise from a participants' expectations, observer's effect on the participants, observer bias, confirmation bias, and other sources. A blind can be imposed on any participant of an experiment, including subjects, researchers, technicians, data analysts, and evaluators. In some cases, while blinding would be useful, it is impossible or unethical. For example, it is not possible to blind a patient to their treatment in a physical therapy intervention. A good clinical protocol ensures that blinding is as effective as possible within ethical and practical constraints.

<span class="mw-page-title-main">Osteoarthritis</span> Form of arthritis caused by degeneration of joints

Osteoarthritis (OA) is a type of degenerative joint disease that results from breakdown of joint cartilage and underlying bone. It is believed to be the fourth leading cause of disability in the world, affecting 1 in 7 adults in the United States alone. The most common symptoms are joint pain and stiffness. Usually the symptoms progress slowly over years. Other symptoms may include joint swelling, decreased range of motion, and, when the back is affected, weakness or numbness of the arms and legs. The most commonly involved joints are the two near the ends of the fingers and the joint at the base of the thumbs, the knee and hip joints, and the joints of the neck and lower back. The symptoms can interfere with work and normal daily activities. Unlike some other types of arthritis, only the joints, not internal organs, are affected.

<span class="mw-page-title-main">Duloxetine</span> Antidepressant medication used also for the treatment of anxiety and chronic pain


Duloxetine, sold under the brand name Cymbalta among others, is a medication used to treat major depressive disorder, generalized anxiety disorder, obsessive-compulsive disorder, fibromyalgia, neuropathic pain and central sensitization. It is taken by mouth.

A nocebo effect is said to occur when a patient's negative expectations for a treatment cause the treatment to have a worse effect than it otherwise would have. For example, when a patient anticipates a side effect of a medication, they can experience that effect even if the "medication" is actually an inert substance. The complementary concept, the placebo effect, is said to occur when positive expectations improve an outcome. The nocebo effect is also said to occur in someone who falls ill owing to the erroneous belief that they were exposed to a physical phenomenon they believe is harmful, such as EM radiation.

<span class="mw-page-title-main">Therapeutic ultrasound</span> Medical procedure for pain relief

Therapeutic ultrasound refers generally to the use of ultrasound for the treatment of a medical condition or for therapeutic benefit. Physiotherapeutic ultrasound was introduced into clinical practice in the 1950s, with lithotripsy introduced in the 1980s. Other uses of ultrasound for therapeutic benefit are at various stages in transitioning from research to clinical use and include: high-intensity focused ultrasound (HIFU), targeted ultrasound drug delivery, trans-dermal ultrasound drug delivery, ultrasound hemostasis, cancer therapy, and ultrasound assisted thrombolysis Ultrasound used for therapeutic benefit often use focused ultrasound waves, however, unfocused ultrasound waves may also be used.

Peter Christian Gøtzsche is a Danish physician, medical researcher, and former leader of the Nordic Cochrane Center at Rigshospitalet in Copenhagen, Denmark. He is a co-founder of the Cochrane Collaboration and has written numerous reviews for the organization. His membership in Cochrane was terminated by its Governing Board of Trustees on 25 September 2018. During the COVID-19 pandemic, Gøtzsche was criticised for spreading disinformation about COVID-19 vaccines.

<span class="mw-page-title-main">Elastic therapeutic tape</span> Pseudo-medicine product; elastic cotton strip with an acrylic adhesive

Elastic therapeutic tape, also called kinesiology tape or kinesiology therapeutic tape, Kinesio tape, k-tape, or KT is an elastic cotton strip with an acrylic adhesive that is purported to ease pain and disability from athletic injuries and a variety of other physical disorders. In individuals with chronic musculoskeletal pain, research suggests that elastic taping may help relieve pain, but not more than other treatment approaches, and no evidence indicates that it can reduce disability in chronic pain cases.

The word placebo was used in a medicinal context in the late 18th century to describe a "commonplace method or medicine" and in 1811 it was defined as "any medicine adapted more to please than to benefit the patient". Although this definition contained a derogatory implication, it did not necessarily imply that the remedy had no effect.

<span class="mw-page-title-main">Irving Kirsch</span> Medical researcher

Irving Kirsch is an American psychologist and academic. He is the Associate Director of the Program in Placebo Studies and a lecturer in medicine at the Harvard Medical School and Beth Israel Deaconess Medical Center. He is also professor emeritus of psychology at the Universities of Hull and Plymouth in the United Kingdom, and the University of Connecticut in the United States. Kirsch is a leading researcher within the field of placebo studies who is noted for his work on placebo effects, antidepressants, expectancy, and hypnosis. He is the originator of response expectancy theory, and his analyses of clinical trials of antidepressants have influenced official treatment guidelines in the United Kingdom. He is the author of the 2009 book The Emperor's New Drugs, which argued most antidepressant medication is effective primarily due to placebo effects.

George Lewith was a professor at the University of Southampton researching alternative medicine and a practitioner of complementary medicine. He was a prominent and sometimes controversial advocate of complementary medicine in the UK.

The philosophy of medicine is a branch of philosophy that explores issues in theory, research, and practice within the field of health sciences, more specifically in topics of epistemology, metaphysics, and medical ethics, which overlaps with bioethics. Philosophy and medicine, have had a long history of overlapping ideas. It was not until the nineteenth century that the professionalization of the philosophy of medicine came to be. In the late twentieth century, debates among philosophers and physicians ensued of whether the philosophy of medicine should be considered a field of its own from either philosophy or medicine. A consensus has since been reached that it is in fact a distinct discipline with its set of separate problems and questions. In recent years there have been a variety of university courses, journals, books, textbooks and conferences dedicated to the philosophy of medicine.

<span class="mw-page-title-main">Hugh MacPherson</span>

Hugh MacPherson was a professor of acupuncture research at the University of York, founder and trustee of the Northern College of Acupuncture, founder and co-ordinator of the international STRICTA group, clinic director of York Clinic, fellow of The College of Medicine, and a practising member of the British Acupuncture Council.

A significant amount of research has been performed on glycosaminoglycans, especially glucosamine and chondroitin, for the treatment of arthritis. These compounds are commonly marketed as nutritional supplements and numerous 'soft therapeutic claims' are made about their health benefits - especially in aging populations. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are major components of cartilage, ingesting glucosamine might nourish joints, and thereby alleviate arthritis symptoms. Authoritative opinions on the actual therapeutic value of these compounds have been very mixed.

Fabrizio Benedetti is professor of physiology and neuroscience at the University of Turin Medical School in Turin, Italy and a researcher in the field of placebo studies. He is known for his research into the placebo and nocebo effects.

Tom Jefferson is a British epidemiologist, based in Rome, Italy, who works for the Cochrane Collaboration. Jefferson is an author and editor of the Cochrane Collaboration's acute respiratory infections group, as well as part of four other Cochrane groups. He was also an advisor to the Italian National Agency for Regional Health Services.

The Centre for Evidence-Based Medicine (CEBM), based in the Nuffield Department of Primary Care Health Sciences at the University of Oxford, is an academic-led centre dedicated to the practice, teaching, and dissemination of high quality evidence-based medicine to improve healthcare in everyday clinical practice. CEBM was founded by David Sackett in 1995. It was subsequently directed by Brian Haynes and Paul Glasziou. Since 2010 it has been led by Professor Carl Heneghan, a clinical epidemiologist and general practitioner.

The infinitesimally low concentration of homeopathic preparations, which often lack even a single molecule of the diluted substance, has been the basis of questions about the effects of the preparations since the 19th century. Modern advocates of homeopathy have proposed a concept of "water memory", according to which water "remembers" the substances mixed in it, and transmits the effect of those substances when consumed. This concept is inconsistent with the current understanding of matter, and water memory has never been demonstrated to exist, in terms of any detectable effect, biological or otherwise.

References

  1. "Dr Jeremy Howick". University of Oxford. Retrieved 24 April 2018.
  2. Fleming, Nic (22 May 2017). "'I knew they were sugar pills but I felt fantastic' – the rise of open-label placebos". the Guardian. Retrieved 24 April 2018.
  3. 1 2 Jeremy Howick (23 February 2011). The Philosophy of Evidence-based Medicine. John Wiley & Sons. ISBN   978-1-4443-4266-6.
  4. "Homepage". Dr. Jeremy Howick. Retrieved 24 April 2018.
  5. "Scientists awarded research grants by the British Medical Association". University of Oxford (Press release). 29 November 2016. Retrieved 24 April 2018.
  6. Barthel, W.; Markwardt, F. (1975). "Jeremy Howick PubMed citations". Biochemical Pharmacology. 24 (20): 1903–4. doi:10.1016/0006-2952(75)90415-3. PMID   20.
  7. "Sigma Xi Member Directory" . Retrieved 22 November 2022.
  8. Howick, Jeremy (2008). Philosophical essentials in evidence-based medicine: Evaluating the epistemological role of double blinding and placebo controls (phd thesis). London School of Economics and Political Science.
  9. 1 2 "Oxford Empathy Programme" . Retrieved 14 August 2020.
  10. "World Rowing". World Rowing. Retrieved 20 April 2020.
  11. "Oxford Philosophy and Medicine Network" . Retrieved 14 August 2020.
  12. "Stoneygate Centre for Excellence in Empathic Healthcare" . Retrieved 22 November 2022.
  13. "Placebos and Back Pain". BBC. Retrieved 20 February 2019.
  14. Howick, Jeremy H. (23 February 2011). The Philosophy of Evidence-based Medicine. Wiley. p. 15. ISBN   978-1-4443-4266-6.
  15. Howick J, Lewith GT, Mebius A, Fanshawe TR, Bishop FL, van Osch M, Van Dulmen AM, Christelis N, Kaptchuk T, Mistiaen P (August 2017). "Positive messages may reduce patient pain: A meta-analysis". European Journal of Integrative Medicine. 11: 31–38. doi:10.1016/j.eujim.2017.03.005.
  16. Howick J, Moscrop A, Mebius A, Fanshawe TR, Lewith G, Bishop FL, Mistiaen P, Roberts NW, Dieninyte E, Hu XY, Aveyard P, Onakpoya IJ (July 2018). "Effects of empathic and positive communication in healthcare consultations: a systematic review and meta-analysis". Journal of the Royal Society of Medicine. 111 (7): 240–252. doi:10.1177/0141076818769477. PMC   6047264 . PMID   29672201.
  17. Howick, Jeremy; Bennett-Weston, Amber; Dudko P.A., Maya; Eva, Kevin (2025). "Uncovering the components of therapeutic empathy through thematic analysis of existing definitions". Patient Education and Counseling. 131. doi:10.1016/j.pec.2024.108596. PMID   39657390.
  18. Howick, Jeremy (14 November 2023). The Power of Placebos: How the Science of Placebos and Nocebos Can Improve Health Care. Johns Hopkins University Press. ISBN   9781421446387.
  19. Howick J, Friedemann C, Tsakok M, Watson R, Tsakok T, Thomas J, Perera R, Fleming S, Heneghan C (May 2013). "Are Treatments More Effective than Placebos? A Systematic Review and Meta-Analysis". PLOS One . 11 (1): e62599. Bibcode:2013PLoSO...862599H. doi: 10.1371/journal.pone.0062599 . PMC   3655171 . PMID   23690944.
  20. Charlesworth JE, Petkovic G, Kelley JM, Hunter M, Onakpoya I, Roberts N, Miller FG, Howick J (May 2017). "Effects of placebos without deception compared with no treatment: A systematic review and meta-analysis" (PDF). Journal of Evidence-Based Medicine (Systematic review and meta-analysis). 10 (2): 97–107. doi: 10.1111/jebm.12251 . PMID   28452193. S2CID   4577402. Archived from the original (PDF) on 5 November 2020. Retrieved 3 August 2022.
  21. Howick, Jeremy H. (19 October 2017). Doctor You. Hachette. ISBN   9781473654235.